The use of psychotropic medications for chronic insomnia in clinical practice

Poluektov M.G.

doi:https://doi.org/10.17116/jnevro202112104261

Poluektov M.G.

Sechenov First Moscow State Medical University (Sechenov University)

ResearcherID: J-7369-2016
ORCID: 0000-0001-6215-0918

The use of psychotropic medications for chronic insomnia in clinical practice

Authors:

Poluektov M.G.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2021;121(4‑2): 61‑66

DOI: 10.17116/jnevro202112104261

Read: 17964 times

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Poluektov MG. The use of psychotropic medications for chronic insomnia in clinical practice. S.S. Korsakov Journal of Neurology and Psychiatry. 2021;121(4‑2):61‑66. (In Russ.)
https://doi.org/10.17116/jnevro202112104261

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова. Спецвыпуски (S.S. Korsakov Journal of Neurology and Psychiatry (special issues))

Использование инфографики авторами научных работ

Close metadata

Recommended articles:

Sleep disorders in Alzheimer’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2026;(4-2):56-62

Diseases of the upper gastrointestinal tract in pregnancy: what should the gastroenterologist consider?. Russian Journal of Evidence-Based Gastroenterology. 2025;(2):30-42

Modern concepts of sleep disturbances associated with mental disorders. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(6):7-12

The effect of insomnia therapy on treatment outcomes in patients with chronic tension headache. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(6):77-83

Dysfunctional pelvic pain in women. Russian Journal of Pain. 2025;(2):32-37

The effect of examination stress on students’ nocturnal sleep metrics studied with custom ECG holter and accelerometer. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(7):122-129

Sleep disorders after COVID-19 in patients with primary headaches. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(8):127-132

Attention deficit hyperactivity disorder: pharmacotherapy in special situations. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(10):59-65

Psychotherapeutic component in the treatment of acute and prevention of chronic postoperative pain. Problems of Balneology, Physiotherapy and Exercise Therapy. 2025;(5-2):44-49

Abstract:

Chronic insomnia is a common sleep disorder. In its treatment, both non-drug and drug approaches are used. The therapeutic concept is based on a three-component model of sleep regulation. Psychotropic drugs of various pharmacological groups are used for the treatment of chronic insomnia. The peculiarities of the effect of these drugs in various clinical situations are discussed.

Keywords:

sleep

insomnia

hypnotics

pharmacotherapy

cognitive-behavior therapy of insomnia

Authors:

Poluektov M.G.

Sechenov First Moscow State Medical University (Sechenov University)

ResearcherID: J-7369-2016
ORCID: 0000-0001-6215-0918

Received:

06.04.2021

Accepted:

06.04.2021

Close metadata

References:

Somnologija i medicina sna. Nacional’noe rukovodstvo pamjati A.M. Vejna i Ja.I. Levina (2-e izd., dop. i pererab.). Pod red. Poluektova M.G.. M.: Medkongress; 2020. (In Russ.).
Riemann D, Baglioni C, Bassetti C, Bjorvatn B, Dolenc Groselj L, Ellis JG, Espie CA, Garcia-Borreguero D, Gjerstad M, Gonçalves M, Hertenstein E, Jansson-Fröjmark M, Jennum PJ, Leger D, Nissen C, Parrino L, Paunio T, Pevernagie D, Verbraecken J, Weeß HG, Wichniak A, Zavalko I, Arnardottir ES, Deleanu OC, Strazisar B, Zoetmulder M, Spiegelhalder K. European guideline for the diagnosis and treatment of insomnia. J Sleep Res. 2017;26(6):675-700. https://doi.org/10.1111/jsr.12594
Kripke DF. Hypnotic drug risks of mortality, infection, depression, and cancer: but lack of benefit. F1000Res. 2016;5:918. https://doi.org/10.12688/f1000research.8729.3
Sweetman A, Putland S, Lack L, McEvoy RD, Adams R, Grunstein R, Stocks N, Kaambwa B, Van Ryswyk E, Gordon C, Vakulin A, Lovato N. The effect of cognitive behavioural therapy for insomnia on sedative-hypnotic use: A narrative review. Sleep Med Rev. 2021;56:101404. https://doi.org/10.1016/j.smrv.2020.101404
Saper CB, Chou TC, Scammell TE. The sleep switch: hypothalamic control of sleep and wakefulness. Trends Neurosci. 2001;24(12):726-731. https://doi.org/10.1016/s0166-2236(00)02002-6
Stone BM, Turner C, Mills SL, Paty I, Patat A, Darwish M, Danjou P. Noise-induced sleep maintenance insomnia: hypnotic and residual effects of zaleplon. Br J Clin Pharmacol. 2002;53(2):196-202. https://doi.org/10.1046/j.-5251.2001.01520.x
Arroll B, Fernando A 3rd, Falloon K, Goodyear-Smith F, Samaranayake C, Warman G. Prevalence of causes of insomnia in primary care: a cross-sectional study. Br J Gen Pract. 2012;62(595):e99-103. https://doi.org/10.3399/bjgp12X625157
Nierenberg AA, Keefe BR, Leslie VC, Alpert JE, Pava JA, Worthington JJ 3rd, Rosenbaum JF, Fava M. Residual symptoms in depressed patients who respond acutely to fluoxetine. J Clin Psychiatry. 1999;60(4):221-225. https://doi.org/10.4088/jcp.v60n0403
Sakurai H, Uchida H, Kato M, Suzuki T, Baba H, Watanabe K, Inada K, Kikuchi T, Katsuki A, Kishida I, Sugawara Kikuchi Y, Yasui-Furukori N; Medical Education Panel of the Japanese Society of Clinical Neuropsychopharmacology. Pharmacological management of depression: Japanese expert consensus. J Affect Disord. 2020;266:626-632. https://doi.org/10.1016/j.jad.2020.01.149
Sateia MJ, Buysse DJ, Krystal AD, Neubauer DN, Heald JL. Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline. J Clin Sleep Med. 2017;13(2):307-349. https://doi.org/10.5664/jcsm.6470
Wilson S, Anderson K, Baldwin D, Dijk DJ, Espie A, Espie C, Gringras P, Krystal A, Nutt D, Selsick H, Sharpley A. British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders: An update. J Psychopharmacol. 2019;33(8):923-947. https://doi.org/10.1177/0269881119855343
Scantlebury A, Mcdaid C, Dawson V, Elphick H, Fairhurst C, Hewitt C, Parker A, Spiers G, Thomas M, Wright K, Beresford B. Non-pharmacological interventions for non-respiratory sleep disturbance in children with neurodisabilities: a systematic review. Dev Med Child Neurol. 2018;60(11):1076-1092. https://doi.org/10.1111/dmcn.13972
Haimov I, Laudon M, Zisapel N, Souroujon M, Nof D, Shlitner A, Herer P, Tzischinsky O, Lavie P. Sleep disorders and melatonin rhythms in elderly people. BMJ. 1994;309(6948):167. https://doi.org/10.1136/bmj.309.6948.167
Wade AG, Crawford G, Ford I, McConnachie A, Nir T, Laudon M, Zisapel N. Prolonged release melatonin in the treatment of primary insomnia: evaluation of the age cut-off for short- and long-term response. Curr Med Res Opin. 2011;27(1):87-98. https://doi.org/10.1185/03007995.2010.537317
Parrino L, Smerieri A, Giglia F, Milioli G, De Paolis F, Terzano MG. Polysomnographic study of intermittent zolpidem treatment in primary sleep maintenance insomnia. Clin Neuropharmacol. 2008;31(1):40-50. https://doi.org/10.1097/wnf.0b013e3180674e0e
Morin CM, Beaulieu-Bonneau S, Ivers H, Vallières A, Guay B, Savard J, Mérette C. Speed and trajectory of changes of insomnia symptoms during acute treatment with cognitive-behavioral therapy, singly and combined with medication. Sleep Med. 2014;15(6):701-707. https://doi.org/10.1016/j.sleep.2014.02.004
Beaulieu-Bonneau S, Ivers H, Guay B, Morin CM. Long-Term Maintenance of Therapeutic Gains Associated With Cognitive-Behavioral Therapy for Insomnia Delivered Alone or Combined With Zolpidem. Sleep. 2017;40(3):zsx002. https://doi.org/10.1093/sleep/zsx002
Morin CM, Bélanger L, LeBlanc M, Ivers H, Savard J, Espie CA, Mérette C, Baillargeon L, Grégoire JP. The natural history of insomnia: a population-based 3-year longitudinal study. Arch Intern Med. 2009;169(5):447-453. https://doi.org/10.1001/archinternmed.2008.610